跳至主要内容
临床试验/DRKS00034796
DRKS00034796招募中不适用

Associations between (Pharmaco-) genetic Markers and Postoperative Inguinal Pain after Inguinal Hernia Repair - (P)Gx-PIP Association Study

niversität Basel, Departement Pharmazeutische Wissenschaften0 个研究点目标入组 350 人开始时间: 2024年8月7日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
350

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Patients with a primary, unilateral, or bilateral inguinal hernia intending to undergo robotic transabdominal preperitoneal (rTAPP) inguinal hernia repair.
  • - Patient signed the informed consent form.
  • - Patient consented to undergo a pharmacogenetic analysis with Stratipharm®, Humatrix AG, and signed the Stratipharm® laboratory requisition.

排除标准

  • - History of chronic pain syndrome.
  • - Pain attributable to current malignant disease or chronic infection.
  • - Lumbar Disc Syndrome with current pain.
  • - Disease impairing central or peripheral nerve function.
  • - Previous neurectomy.
  • - Opioid addiction and/or enrollment in an opioid substitution program.
  • - Recurrent inguinal hernia.
  • - Patients with prior operations affecting sensitivity in the inguinal region (e.g., urological surgery).
  • - Pregnancy.
  • - Advanced dementia or other cognitive impairments hindering comprehension of the study protocol.

研究者

发起方
niversität Basel, Departement Pharmazeutische Wissenschaften

相似试验

Associations between (Pharmaco-) genetic Markers and... | 临床试验